» Articles » PMID: 33631522

Generation and Characterization of Induced Pluripotent Stem Cells from a Family Carrying the BRCA1 Mutation C.3612delA

Overview
Journal Stem Cell Res
Publisher Elsevier
Specialty Cell Biology
Date 2021 Feb 25
PMID 33631522
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

How BRCA1 germline mutations predispose to cancer remains poorly understood. Induced pluripotent stem cells (iPSCs) represent an emerging model to investigate the molecular mechanisms underlying malignant transformation in primary cells from individuals who are carriers of deleterious mutations in the BRCA1 gene. Here we report the generation and characterization of iPSC lines from a female donor harboring a germline c.3612delA mutation in the BRCA1 gene and her daughter who does not carry the mutation. Skin fibroblasts were reprogrammed using non-integrative Sendai virus and characterized for their pluripotent properties. These iPSCs are a valuable cellular model for personalized pre-clinical research in the context of BRCA1 mutant hereditary cancers.

Citing Articles

Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis.

Yucer N, Ahdoot R, Workman M, Laperle A, Recouvreux M, Kurowski K Cell Rep. 2021; 37(13):110146.

PMID: 34965417 PMC: 9000920. DOI: 10.1016/j.celrep.2021.110146.


Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significance.

Ozgencil M, Barwell J, Tischkowitz M, Izatt L, Kesterton I, Simpson M PLoS One. 2021; 16(12):e0260852.

PMID: 34855882 PMC: 8638976. DOI: 10.1371/journal.pone.0260852.